Michael Allen Jerman

CIK: 0001979732

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TCRT

Alaunos Therapeutics, Inc.

Director

INTI

Inhibitor Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

TCRT
Alaunos Therapeutics, Inc.
Oct 6, 2026
Award(A)
Direct
21K shares at avg. $0.74$16K
TCRT
Alaunos Therapeutics, Inc.
Jul 23, 2026
Award(A)
Direct
8.1K shares at avg. $1.92$16K
INTI
Inhibitor Therapeutics, Inc.
May 4, 2026
Award(A)
Direct
50K shares-
TCRT
Alaunos Therapeutics, Inc.
Apr 29, 2026
Award(A)
Direct
6K shares at avg. $2.59$16K
TCRT
Alaunos Therapeutics, Inc.
Jan 12, 2026
Award(A)
Direct
5.4K shares at avg. $2.89$16K
TCRT
Alaunos Therapeutics, Inc.
Nov 21, 2025
Award(A)
Direct
4.2K shares at avg. $3.16$13K
TCRT
Alaunos Therapeutics, Inc.
Jul 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
10K shares-
TCRT
Alaunos Therapeutics, Inc.
Jul 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
3.2K shares-
INTI
Inhibitor Therapeutics, Inc.
Apr 1, 2025
Award(A)
Direct
50K shares-

		Type	Shares	Price		Ownership
Oct 6, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	20,990	$0.74	$15,625	Direct
Jul 23, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	8,138	$1.92	$15,625	Direct
May 4, 2026	INTI Inhibitor Therapeutics, Inc.	Award(A)	50,000	-	$0	Direct
Apr 29, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	6,032	$2.59	$15,623	Direct
Jan 12, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	5,406	$2.89	$15,623	Direct
Nov 21, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A)	4,183	$3.16	$13,218	Direct
Jul 15, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	10,000	-	-	Direct
Jul 15, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	3,200	-	-	Direct
Apr 1, 2025	INTI Inhibitor Therapeutics, Inc.	Award(A)	50,000	-	-	Direct

1-9 of 9 transactions

About Jerman Michael Allen

Jerman Michael Allen (SEC CIK 0001979732) files insider reports with the SEC as Director of Alaunos Therapeutics, Inc. (TCRT) and Director of Inhibitor Therapeutics, Inc. (INTI).

Signal8 holds 9 ownership filings by Jerman Michael Allen (1 Form 3, 8 Form 4), filed between Apr 7, 2025 and Oct 8, 2026. Those filings report 9 transactions, from Apr 1, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jerman Michael Allen's filings is in FORT LAUDERDALE, FL.

Recent filings by Jerman Michael Allen

Oct 6, 2026: Grant or award of TCRT shares (Form 4, code A).
Jul 23, 2026: Grant or award of TCRT shares (Form 4, code A).
May 4, 2026: Grant or award of INTI shares (Form 4, code A).
Apr 29, 2026: Grant or award of TCRT shares (Form 4, code A).
Jan 12, 2026: Grant or award of TCRT shares (Form 4, code A).

Other insiders filing for Alaunos Therapeutics, Inc. (TCRT)

Fairmount Funds Management LLC, Director
Weis Holger, CEO
Vieser Jaime, Director
Postma Robert W, Director
Groenewald Ferdinand, VP, Finance
Hogue Dale Curtis Jr.

How to read Form 4 transaction codes